Shopping Cart
- Remove All
Your shopping cart is currently empty
YKL-06-062 is a second-generation salt-inducible kinase (SIK) inhibitor that targets SIK1, SIK2, and SIK3, with IC50 values of 2.12 nM, 1.40 nM, and 2.86 nM, respectively.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $93 | In Stock | |
| 5 mg | $228 | In Stock | |
| 10 mg | $372 | In Stock | |
| 25 mg | $629 | In Stock | |
| 50 mg | $896 | In Stock | |
| 100 mg | $1,220 | In Stock | |
| 500 mg | $2,450 | In Stock |
| Description | YKL-06-062 is a second-generation salt-inducible kinase (SIK) inhibitor that targets SIK1, SIK2, and SIK3, with IC50 values of 2.12 nM, 1.40 nM, and 2.86 nM, respectively. |
| Targets&IC50 | SIK1:2.12 nM, SIK3:2.86 nM, SIK2:1.40 nM |
| In vitro | In a dose-dependent manner, YKL 06-062 (0.0004-16 μM; 3 h) enhances MITF mRNA expression.[1] |
| Molecular Weight | 525.69 |
| Formula | C31H39N7O |
| Cas No. | 2172617-16-0 |
| Smiles | CN1CCN(CC1)c1ccc(Nc2ncc3CN(C(=O)N(C4CCCCC4)c3n2)c2c(C)cccc2C)cc1 |
| Relative Density. | 1.229 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: < 1 mg/mL (insoluble or slightly soluble), Sonication is recommended. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.